Optimal Value-Based Therapy

Ken Schaecher, MD

Video Categories: Polycythemia Vera

Listen as Ken Schaecher, MD discusses the optimal value-based therapy for treatment of polycythemia vera.

Supported through funding from Incyte
March 24, 2015

In Pursuit of Targeted Therapies

As we learn more about a person’s genetic makeup, the more we are able to target medicines to his/her needs and benefit. With continued research, Dr. Stainthorpe explains, we will be able to identify markers that allow us to target medicines more precisely to get better performance and reduce waste.

November 3, 2014

Important Tools to Educate Patients with PV

Ruben A. Mesa, MD, Mayo Clinic, Scottsdale Arizona describes why polycythemia vera is a difficult disease for patients to understand and what tools are important to educate. Supported through funding from Incyte